Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (361-370 of 369) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 369 results.
The Lancet. HIV|March 26, 2022
Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysisAshar Dhana, Yohhei Hamada, Andre P Kengne, et al.
The Lancet. HIV|August 9, 2025
The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling studyEmily P Hyle, Linda-Gail Bekker, Suzanne M McCluskey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2022
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir SizeThomas A Rasmussen, Sunil K Ahuja, Locadiah Kuwanda, et al.
Scientific Reports|May 27, 2020
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment responseAdam Penn-Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, et al.
The Lancet. Global Health|May 18, 2023
Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant dataTobias Broger, Lisa Koeppel, Helena Huerga, et al.
International Journal of Epidemiology|April 11, 2015
CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and AfricaElvin H Geng, Torsten B Neilands, Rodolphe Thièbaut, et al.
The Lancet. Infectious Diseases|November 20, 2021
Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysisAshar Dhana, Yohhei Hamada, Andre P Kengne, et al.
NEJM Evidence|May 22, 2023
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV InfectionJens D Lundgren, Abdel G Babiker, Shweta Sharma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2014
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries, Dorita Avila, Keri N Althoff, et al.
Pageof 37

Showing results (361-370 of 369) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 369 results.
The Lancet. HIV|March 26, 2022
Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysisAshar Dhana, Yohhei Hamada, Andre P Kengne, et al.
The Lancet. HIV|August 9, 2025
The clinical and economic impact of genotypic resistance testing for people diagnosed with persistent virological non-suppression on tenofovir-lamivudine-dolutegravir in South Africa: a modelling studyEmily P Hyle, Linda-Gail Bekker, Suzanne M McCluskey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2022
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir SizeThomas A Rasmussen, Sunil K Ahuja, Locadiah Kuwanda, et al.
Scientific Reports|May 27, 2020
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment responseAdam Penn-Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, et al.
The Lancet. Global Health|May 18, 2023
Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant dataTobias Broger, Lisa Koeppel, Helena Huerga, et al.
International Journal of Epidemiology|April 11, 2015
CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and AfricaElvin H Geng, Torsten B Neilands, Rodolphe Thièbaut, et al.
The Lancet. Infectious Diseases|November 20, 2021
Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysisAshar Dhana, Yohhei Hamada, Andre P Kengne, et al.
NEJM Evidence|May 22, 2023
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV InfectionJens D Lundgren, Abdel G Babiker, Shweta Sharma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2014
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries, Dorita Avila, Keri N Althoff, et al.
Pageof 37